Estimation of death rates in US states with small subpopulations.

Abstract:

:In US states with small subpopulations, the observed mortality rates are often zero, particularly among young ages. Because in life tables, death rates are reported mostly on a log scale, zero mortality rates are problematic. To overcome the observed zero death rates problem, appropriate probability models are used. Using these models, observed zero mortality rates are replaced by the corresponding expected values. This enables logarithmic transformations and, in some cases, the fitting of the eight-parameter Heligman-Pollard model to produce mortality estimates for ages 0-130 years, a procedure illustrated in terms of mortality data from several states.

journal_name

Stat Med

journal_title

Statistics in medicine

authors

Voulgaraki A,Wei R,Kedem B

doi

10.1002/sim.6385

subject

Has Abstract

pub_date

2015-05-20 00:00:00

pages

1940-52

issue

11

eissn

0277-6715

issn

1097-0258

journal_volume

34

pub_type

杂志文章
  • Regression analysis of clustered interval-censored data with informative cluster size.

    abstract::Interval-censored data are commonly found in studies of diseases that progress without symptoms, which require clinical evaluation for detection. Several techniques have been suggested with independent assumption. However, the assumption will not be valid if observations come from clusters. Furthermore, when the clust...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4042

    authors: Kim YJ

    更新日期:2010-12-10 00:00:00

  • Goodman and Kruskal's lambda: a new look at an old measure of association.

    abstract::We examine Goodman and Kruskal's lambda using Efron's approach to regression and analysis of variance (ANOVA) for zero-one outcome data. For a binary response cross-classified by a single nominal predictor, we present a computationally simple ANOVA table in which lambda is analogous to Pearson's R-square. We character...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780080511

    authors: Makuch RW,Rosenberg PS,Scott G

    更新日期:1989-05-01 00:00:00

  • A joint modeling approach to data with informative cluster size: robustness to the cluster size model.

    abstract::In many biomedical and epidemiological studies, data are often clustered due to longitudinal follow up or repeated sampling. While in some clustered data the cluster size is pre-determined, in others it may be correlated with the outcome of subunits, resulting in informative cluster size. When the cluster size is info...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4239

    authors: Chen Z,Zhang B,Albert PS

    更新日期:2011-07-10 00:00:00

  • Power and money in cluster randomized trials: when is it worth measuring a covariate?

    abstract::The power to detect a treatment effect in cluster randomized trials can be increased by increasing the number of clusters. An alternative is to include covariates into the regression model that relates treatment condition to outcome. In this paper, formulae are derived in order to evaluate both strategies on basis of ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.2297

    authors: Moerbeek M

    更新日期:2006-08-15 00:00:00

  • Two-stage sampling in pharmaceutical applications.

    abstract::In the pharmaceutical industry, some tests for quality assurance before, during and after the manufacture of a drug product involve a two-stage sampling technique. We propose statistical testing procedures in a two-stage sampling problem with large within-class sample sizes. We also derive a two-stage sampling plan by...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780122104

    authors: Shao J,Chow SC

    更新日期:1993-11-15 00:00:00

  • A metastasis or a second independent cancer? Evaluating the clonal origin of tumors using array copy number data.

    abstract::When a cancer patient develops a new tumor it is necessary to determine if it is a recurrence (metastasis) of the original cancer, or an entirely new occurrence of the disease. This is accomplished by assessing the histo-pathology of the lesions. However, there are many clinical scenarios in which this pathological di...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3866

    authors: Ostrovnaya I,Olshen AB,Seshan VE,Orlow I,Albertson DG,Begg CB

    更新日期:2010-07-10 00:00:00

  • Small clinical trials: are they all bad?

    abstract::Statisticians have long argued that randomized controlled trials should be sufficiently large to achieve their purpose, and for common diseases with major public health implications this has brought many benefits. However, there are many instances where it is unrealistic to expect clinicians to provide the information...

    journal_title:Statistics in medicine

    pub_type: 杂志文章,评审

    doi:10.1002/sim.4780140204

    authors: Matthews JN

    更新日期:1995-01-30 00:00:00

  • A sexually transmitted infection screening algorithm based on semiparametric regression models.

    abstract::Sexually transmitted infections (STIs) with Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis are among the most common infectious diseases in the United States, disproportionately affecting young women. Because a significant portion of the infections present no symptoms, infection control relies...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.6515

    authors: Li Z,Liu H,Tu W

    更新日期:2015-09-10 00:00:00

  • Concordance correlation coefficient applied to discrete data.

    abstract::In any field in which decisions are subject to measurements, interchangeability between the methods used to obtain these measurements is essential. To consider methods as interchangeable, a certain degree of agreement is needed between the measurements they provide. The concordance correlation coefficient is an index ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.2397

    authors: Carrasco JL,Jover L

    更新日期:2005-12-30 00:00:00

  • Two-stage residual inclusion for survival data and competing risks-An instrumental variable approach with application to SEER-Medicare linked data.

    abstract::Instrumental variable is an essential tool for addressing unmeasured confounding in observational studies. Two-stage predictor substitution (2SPS) estimator and two-stage residual inclusion (2SRI) are two commonly used approaches in applying instrumental variables. Recently, 2SPS was studied under the additive hazards...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.8071

    authors: Ying A,Xu R,Murphy J

    更新日期:2019-05-10 00:00:00

  • Sample size calculation for clinical trials with correlated count measurements based on the negative binomial distribution.

    abstract::Statistical inference based on correlated count measurements are frequently performed in biomedical studies. Most of existing sample size calculation methods for count outcomes are developed under the Poisson model. Deviation from the Poisson assumption (equality of mean and variance) has been widely documented in pra...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.8378

    authors: Li D,Zhang S,Cao J

    更新日期:2019-12-10 00:00:00

  • Dropouts in the AB/BA crossover design.

    abstract::Missing data arise in crossover trials, as they do in any form of clinical trial. Several papers have addressed the problems that missing data create, although almost all of these assume that the probability that a planned observation is missing does not depend on the value that would have been observed; that is, the ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4497

    authors: Ho WK,Matthews JN,Henderson R,Farewell D,Rodgers LR

    更新日期:2012-07-20 00:00:00

  • Sample size calculation for clinical trials in which entry criteria and outcomes are counts of events. ACIP Investigators. Asymptomatic Cardiac Ischemia Pilot.

    abstract::In many chronic diseases, therapy aims to prevent or reduce the frequency of episodes of a disease manifestation, for example cardiac ischaemic episodes or epileptic seizures. Entry criteria for clinical trials typically include a minimum number of episodes within a baseline period, and regression to the mean should b...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780130806

    authors: McMahon RP,Proschan M,Geller NL,Stone PH,Sopko G

    更新日期:1994-04-30 00:00:00

  • Non-inferiority trials: the 'at least as good as' criterion with dichotomous data.

    abstract::The 'at least as good as' criterion, introduced by Laster and Johnson for a continuous response variate, is developed here for applications with dichotomous data. This approach is adaptive in nature, as the margin of non-inferiority is not taken as a fixed difference; it varies as a function of the positive control re...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.2476

    authors: Laster LL,Johnson MF,Kotler ML

    更新日期:2006-04-15 00:00:00

  • A comparison of three approaches to estimate exposure-specific incidence rates from population-based case-control data.

    abstract::In population-based case-control studies, an attempt is made to identify all incident cases diagnosed in a specified population during a fixed time interval. Assuming that this goal is met allows one to obtain measures of risk other than relative risks. In this paper, we describe three approaches to estimate exposure-...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780130526

    authors: Benichou J,Wacholder S

    更新日期:1994-03-15 00:00:00

  • Designing a study to evaluate the benefit of a biomarker for selecting patient treatment.

    abstract::Biomarkers that predict the efficacy of treatment can potentially improve clinical outcomes and decrease medical costs by allowing treatment to be provided only to those most likely to benefit. We consider the design of a randomized clinical trial in which one objective is to evaluate a treatment selection marker. The...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.6564

    authors: Janes H,Brown MD,Pepe MS

    更新日期:2015-11-30 00:00:00

  • Sam Greenhouse's years at the Census Bureau and the UNRRA.

    abstract::Sam Greenhouse joined the Census Bureau as a clerk at an interesting time period for the agency. The first use of sampling in the decennial census occurred in 1940. There was a major expansion of the amount of data collected. The organization of the Census Bureau underwent radical changes, including the growth of the ...

    journal_title:Statistics in medicine

    pub_type: 传,历史文章,杂志文章

    doi:10.1002/sim.1627

    authors: Keller J,Clark CZ

    更新日期:2003-11-15 00:00:00

  • Assessing time-by-covariate interactions in proportional hazards regression models using cubic spline functions.

    abstract::Proportional hazards (or Cox) regression is a popular method for modelling the effects of prognostic factors on survival. Use of cubic spline functions to model time-by-covariate interactions in Cox regression allows investigation of the shape of a possible covariate-time dependence without having to specify a specifi...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780131007

    authors: Hess KR

    更新日期:1994-05-30 00:00:00

  • Estimating probit models with self-selected treatments.

    abstract::Outcomes research often requires estimating the impact of a binary treatment on a binary outcome in a non-randomized setting, such as the effect of taking a drug on mortality. The data often come from self-selected samples, leading to a spurious correlation between the treatment and outcome when standard binary depend...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.2226

    authors: Bhattacharya J,Goldman D,McCaffrey D

    更新日期:2006-02-15 00:00:00

  • A simple test for synergy for a small number of combinations.

    abstract::A method for detecting deviations from the Loewe additive drug combination reference model for in vitro drug combination experimentation is described. It is often difficult to fit a response surface model to drug combination data, especially in situations where the experimental design contains a sparse set of combinat...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.5905

    authors: Novick SJ

    更新日期:2013-12-20 00:00:00

  • Multiple imputation for left-censored biomarker data based on Gibbs sampling method.

    abstract::Biomarkers, increasingly used in biomedical studies for the diagnosis and prognosis of acute and chronic diseases, provide insight into the effectiveness of treatments and potential pathways that can be used to guide future treatment targets. The measurement of these markers is often limited by the sensitivity of the ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4503

    authors: Lee M,Kong L,Weissfeld L

    更新日期:2012-07-30 00:00:00

  • Chronic disease prevention: public health potential and research needs.

    abstract::This paper, arising out of an event to honour the statistical and scientific contributions of Professor Peter Armitage, is concerned with research strategies and needs for chronic disease prevention. A few highlights from recent intervention trials for the prevention of cancer, cardiovascular disease, fractures and di...

    journal_title:Statistics in medicine

    pub_type:

    doi:10.1002/sim.2045

    authors: Prentice RL

    更新日期:2004-11-30 00:00:00

  • On the association between variables with lower detection limits.

    abstract::In this paper, we define a modified version τ(b) of Kendall's tau to measure the association in a pair (X,Y) of random variables subject to fixed left censoring due to known lower detection limits. We provide a nonparametric estimator of τ(b) and investigate its asymptotic properties. We then assume an Archimedean cop...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4319

    authors: Romdhani H,Lakhal-Chaieb L

    更新日期:2011-11-20 00:00:00

  • Group sequential large sample T2-like chi2 tests for multivariate observations.

    abstract::In many studies, a K degree of freedom large sample chi2 test is used to assess the effect of treatment on a multivariate response, such as an omnibus T2-like test of a difference between two treatment groups in any of K repeated measures. Alternately, a K df chi2 test may be used to test the equality of K+1 groups in...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.1637

    authors: Lachin JM,Greenhouse SW,Bautista OM

    更新日期:2003-11-15 00:00:00

  • Level-adjusted funnel plots based on predicted marginal expectations: an application to prophylactic antibiotics in gallstone surgery.

    abstract::Funnel plots are widely used to visualize grouped data, for example, in institutional comparison. This paper extends the concept to a multi-level setting, displaying one level at a time, adjusted for the other levels, as well as for covariates at all levels. These level-adjusted funnel plots are based on a Markov chai...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.5677

    authors: Lindhagen L,Darkahi B,Sandblom G,Berglund L

    更新日期:2014-09-20 00:00:00

  • Identifying optimal risk windows for self-controlled case series studies of vaccine safety.

    abstract::In vaccine safety studies, subjects are considered at increased risk for adverse events for a period of time after vaccination known as risk window. To our knowledge, risk windows for vaccine safety studies have tended to be pre-defined and not to use information from the current study. Inaccurate specification of the...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4125

    authors: Xu S,Zhang L,Nelson JC,Zeng C,Mullooly J,McClure D,Glanz J

    更新日期:2011-03-30 00:00:00

  • Likelihood-based methods for regression analysis with binary exposure status assessed by pooling.

    abstract::The need for resource-intensive laboratory assays to assess exposures in many epidemiologic studies provides ample motivation to consider study designs that incorporate pooled samples. In this paper, we consider the case in which specimens are combined for the purpose of determining the presence or absence of a pool-w...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4426

    authors: Lyles RH,Tang L,Lin J,Zhang Z,Mukherjee B

    更新日期:2012-09-28 00:00:00

  • Designing therapeutic cancer vaccine trials with delayed treatment effect.

    abstract::Arming the immune system against cancer has emerged as a powerful tool in oncology during recent years. Instead of poisoning a tumor or destroying it with radiation, therapeutic cancer vaccine, a type of cancer immunotherapy, unleashes the immune system to combat cancer. This indirect mechanism-of-action of vaccines p...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.7157

    authors: Xu Z,Zhen B,Park Y,Zhu B

    更新日期:2017-02-20 00:00:00

  • Parametric randomization-based methods for correcting for treatment changes in the assessment of the causal effect of treatment.

    abstract::We develop parametric maximum likelihood methods to adjust for treatment changes during follow-up in order to assess the causal effect of treatment in clinical trials with time-to-event outcomes. The accelerated failure time model of Robins and Tsiatis relates each observed event time to the underlying event time that...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.1618

    authors: Walker AS,White IR,Babiker AG

    更新日期:2004-02-28 00:00:00

  • Sequential designs for phase III clinical trials incorporating treatment selection.

    abstract::Most statistical methodology for phase III clinical trials focuses on the comparison of a single experimental treatment with a control. An increasing desire to reduce the time before regulatory approval of a new drug is sought has led to development of two-stage or sequential designs for trials that combine the defini...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.1362

    authors: Stallard N,Todd S

    更新日期:2003-03-15 00:00:00